Bioflor

Bioflor Adverse Reactions

Manufacturer:

Biocodex

Distributor:

DKSH

Marketer:

Servier
Full Prescribing Info
Adverse Reactions
Capsule: Some rare epigastric disturbances have been reported, not requiring that treatment be discontinued. Constipation: unknown frequency.
Powder for oral suspension: The side effects which have been reported are classified hereafter by system-organ class and by frequency defined as: very common (≥1/10), common (≥ 1/100, < 1/10), uncommon (≥ 1/1,000, < 1/100), rare (≥ 1/10,000, < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in the order of decreasing seriousness. (See table.)

Click on icon to see table/diagram/image

Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in